Mitchell Psotka News Today

These first “SAMDs” leverage ECGs to pick up worsening EF and hypertrophic cardiomyopathy, but more loom on the horizon.

These “SAMDs” leverage ECGs to pick up worsening EF and hypertrophic cardiomyopathy, but more loom on the horizon.

While the concept has potential, more research is needed on implementation and patient selection, says Mitchell Psotka.

Daily step counts between 1000 and 5000 are significantly associated with lower rates of heart failure symptoms and physical limitations.

Two first-person blogs made this month’s most popular lineup, as did stories from the EHRA meeting and a feature on ChatGPT.

The decision pathway supplements HF guidelines by “walking” clinicians through diagnosis and referrals, notes Mitchell Psotka.

The legislation appears to be a step toward saving patients money, but only time will tell if it delivers, one expert notes.

Researchers say health care professionals should now focus on appropriate dosing of diuretics and implementation of medicines proven to improve quality-of-life and clinical outcomes for people living with heart failure

Regardless of their Medicare plan, every patient hits catastrophic coverage by year’s end at current pricing, new numbers show.

EMPULSE Trial showed hospitalized adults taking empagliflozin had reduced rates of death or re-hospitalization due to acute heart failure